Acumen Pharmaceuticals, Inc. · Brief

Next report

No upcoming report date.

Expected move

No implied move.

2 reportsHistory

—≥ implied

Q2 FY26±15.3%▲+1.62%×0.11

Q3 FY26—▲+14.65%—

quarterimplied−20%0+20%realized×

Q3 FY26—▲+14.65%—

Q2 FY26±15.3%▲+1.62%×0.11

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

—

ABOS report session

No linked exposure.

Oct 23impliedImplied move: ±54.7% into Oct 26 earnings (Oct 23 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.